Impact of Oral Vitamin D3 Supplementation on Quality of Life in Patients with Irritable Bowel Syndrome (IBS): Impact of Oral Vitamin D3 Supplementation on Quality of Life

Anam  Zubair; Bahisht Rizwan; Hooria  Ajmal; Sahar  Imran; Amsa  Fatima

doi:10.54393/pjhs.v4i09.988

Authors

Anam Zubair University Institute of Diet and Nutritional Sciences, Faculty of Allied Health Sciences, The University of Lahore, Lahore, Pakistan
Bahisht Rizwan University Institute of Diet and Nutritional Sciences, Faculty of Allied Health Sciences, The University of Lahore, Lahore, Pakistan
Hooria Ajmal University Institute of Diet and Nutritional Sciences, Faculty of Allied Health Sciences, The University of Lahore, Lahore, Pakistan
Sahar Imran University Institute of Diet and Nutritional Sciences, Faculty of Allied Health Sciences, The University of Lahore, Lahore, Pakistan
Amsa Fatima University Institute of Diet and Nutritional Sciences, Faculty of Allied Health Sciences, The University of Lahore, Lahore, Pakistan

DOI:

https://doi.org/10.54393/pjhs.v4i09.988

Keywords:

Vitamin D, Quality of Life, Irritable Bowel Syndrome, Supplementation

Abstract

Irritable Bowel Syndrome (IBS) is the most prevailing complicated gastrointestinal disorder with an approximate 11.2% global prevalence, indicating a critical need for an improved understanding of the condition. Several studies suggested that adult IBS patients' symptoms and quality of life are markedly improved by vitamin D supplementation. Objective: To analyze the impact of oral Vitamin D3 supplementation on quality of life in patients with Intestinal Bowel Syndrome. Methods: A randomized control trial (RCT) was conducted for 9 months. Non-probability purposive sampling technique was used to allocate 24 participants aged between 25 to 35 years and BMI of 18–25. The participants were separated into two groups, G1 and G0. G1 received 50,000 IU of vitamin D weekly for 6 weeks. Results: Before the intervention, values of IBS-QOL for G1 were estimated as 1.8±0.71 while at the end of the intervention, there was a visible improvement in the values of IBS-QoL with the mean and SD determined as 2.4±0.51. The p-value for G1 was 0.002 which shows that there were significant improvements in the G1. Conclusions: The present study concluded that vitamin D supplementation can benefit patients with IBS by adding 5000 IU of vitamin D supplementation.

References

Abbasnezhad A, Amani R, Hajiani E, Alavinejad P, Cheraghian B, Ghadiri A. Effect of vitamin D on gastrointestinal symptoms and health‐related quality of life in irritable bowel syndrome patients: a randomized double‐blind clinical trial. Neurogastroenterology & Motility. 2016 Oct; 28(10): 1533-44. doi: 10.1111/nmo.12851. DOI: https://doi.org/10.1111/nmo.12851

Ng QX, Soh AY, Loke W, Lim DY, Yeo WS. The role of inflammation in irritable bowel syndrome (IBS). Journal of Inflammation Research. 2018 Sep; 11: 345-9. doi: 10.2147/JIR.S174982. DOI: https://doi.org/10.2147/JIR.S174982

Bachani P, Kumar L, Kumar N, Fatima M, Naz S, Memon MK, et al. Prevalence of irritable bowel syndrome and frequency of symptoms in the general population of Pakistan. Cureus. 2021 Jan; 13(1): e12541. doi: 10.7759/cureus.12541. DOI: https://doi.org/10.7759/cureus.12541

Nwosu BU, Maranda L, Candela N. Vitamin D status in pediatric irritable bowel syndrome. PLoS One. 2017 Feb; 12(2): e0172183. doi: 10.1371/journal.pone.0172183. DOI: https://doi.org/10.1371/journal.pone.0172183

Agnello M, Carroll LN, Imam N, Pino R, Palmer C, Varas I, et al. Gut microbiome composition and risk factors in a large cross-sectional IBS cohort. BMJ Open Gastroenterology. 2020 Apr; 7(1): e000345. doi: 10.1136/bmjgast-2019-000345. DOI: https://doi.org/10.1136/bmjgast-2019-000345

Rajilić–Stojanović M, Biagi E, Heilig HG, Kajander K, Kekkonen RA, Tims S, et al. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology. 2011 Nov; 141(5): 1792-801. doi: 10.1053/j.gastro.2011.07.043. DOI: https://doi.org/10.1053/j.gastro.2011.07.043

Roberts C, Albusoda A, Farmer AD, Aziz Q. Factors influencing rectal hypersensitivity in irritable bowel syndrome: A systematic review and meta‐analysis. Neurogastroenterology & Motility. 2023 Apr; 35(4): e14515. doi: 10.1111/nmo.14515. DOI: https://doi.org/10.1111/nmo.14515

Black CJ, and Ford AC. Global burden of irritable bowel syndrome: trends, predictions and risk factors. Nature Reviews Gastroenterology & Hepatology. 2020 Aug; 17(8): 473-86. doi: 10.1038/s41575-020-0286-8. DOI: https://doi.org/10.1038/s41575-020-0286-8

Di Rosa C, Altomare A, Terrigno V, Carbone F, Tack J, Cicala M, et al. Constipation-predominant irritable bowel syndrome (IBS-C): Effects of different nutritional patterns on intestinal dysbiosis and symptoms. Nutrients. 2023 Mar; 15(7): 1647. doi: 10.3390/nu15071647. DOI: https://doi.org/10.3390/nu15071647

Dehghanian L, Rustee A, Hekmatdoost A. Effects of vitamin D3 supplementation on clinical symptoms in patients with irritable bowel syndrome and vitamin D deficiency: clinical trials. Iranian Journal of Nutrition Sciences & Food Technology. 2016 Apr; 11(1): 11-8.

Drossman DA. Functional gastrointestinal disorders: history, pathophysiology, clinical features, and Rome IV. Gastroenterology. 2016 May; 150(6): 1262-79. doi: 10.1053/j.gastro.2016.02.032. DOI: https://doi.org/10.1053/j.gastro.2016.02.032

Cantorna MT, Snyder L, Lin YD, Yang L. Vitamin D and 1, 25 (OH) 2D regulation of T cells. Nutrients. 2015 Apr; 7(4): 3011-21. doi: 10.3390/nu7043011. DOI: https://doi.org/10.3390/nu7043011

Frändemark Å, Törnblom H, Jakobsson S, Simrén M. Work productivity and activity impairment in irritable bowel syndrome (IBS): a multifaceted problem. Official journal of the American College of Gastroenterology| ACG. 2018 Oct; 113(10): 1540-9. doi: 10.1038/s41395-018-0262-x. DOI: https://doi.org/10.1038/s41395-018-0262-x

Głąbska D, Kołota A, Lachowicz K, Skolmowska D, Stachoń M, Guzek D. Vitamin d supplementation and mental health in inflammatory bowel diseases and irritable bowel syndrome patients: A systematic review. Nutrients. 2021 Oct; 13(10): 3662. doi: 10.3390/nu13103662. DOI: https://doi.org/10.3390/nu13103662

Patel P, Bercik P, Morgan DG, Bolino C, Pintos-Sanchez MI, Moayyedi P, et al. Prevalence of organic disease at colonoscopy in patients with symptoms compatible with irritable bowel syndrome: cross-sectional survey. Scandinavian Journal of Gastroenterology. 2015 Jul; 50(7): 816-23. doi: 10.3109/00365521.2015.1007079. DOI: https://doi.org/10.3109/00365521.2015.1007079

Mahon BD, Wittke A, Weaver V, Cantorna MT. The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. Journal of Cellular Biochemistry. 2003 Aug; 89(5): 922-32. doi: 10.1002/jcb.10580. DOI: https://doi.org/10.1002/jcb.10580

Lee KN, and Lee OY. Intestinal microbiota in pathophysiology and management of irritable bowel syndrome. World Journal of Gastroenterology: WJG. 2014 Jul; 20(27): 8886. doi: 10.3748/wjg.v20.i10.2456. DOI: https://doi.org/10.3748/wjg.v20.i10.2456

Frändemark Å, Törnblom H, Hreinsson JP, Andresen V, Benninga MA, Corazziari ES, et al. Work productivity and activity impairment in disorders of gut‐brain interaction: Data from the Rome Foundation Global Epidemiology Study. United European Gastroenterology Journal. 2023 Jul; 11(6): 503-13. doi: 10.1002/ueg2.12425. DOI: https://doi.org/10.1002/ueg2.12425

El Amrousy D, Hassan S, El Ashry H, Yousef M, Hodeib H. Vitamin D supplementation in adolescents with irritable bowel syndrome: Is it useful? A randomized controlled trial. Saudi Journal of Gastroenterology: Official Journal of the Saudi Gastroenterology Association. 2018 Mar; 24(2): 109. doi: 10.4103/sjg.SJG_438_17. DOI: https://doi.org/10.4103/sjg.SJG_438_17

Khalighi Sikaroudi M, Mokhtare M, Janani L, Faghihi Kashani AH, Masoodi M, Agah S, et al. Vitamin D3 Supplementation in Diarrhea-Predominant Irritable Bowel Syndrome Patients: The Effects on Symptoms Improvement, Serum Corticotropin-Releasing Hormone, and Interleukin-6–A Randomized Clinical Trial. Complementary Medicine Research. 2020 Oct; 27(5):302-9. doi: 10.1159/000506149. DOI: https://doi.org/10.1159/000506149

Foxx-Orenstein AE. New and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologists. Therapeutic Advances in Gastroenterology. 2016 May; 9(3): 354-75. doi: 10.1177/1756283X16633050. DOI: https://doi.org/10.1177/1756283X16633050

Williams CE, Williams EA, Corfe BM. Vitamin D supplementation in people with IBS has no effect on symptom severity and quality of life: results of a randomised controlled trial. European Journal of Nutrition. 2022 Feb; 61: 299-308. doi: 10.1007/s00394-021-02633-w. DOI: https://doi.org/10.1007/s00394-021-02633-w

Linsalata M, Riezzo G, Orlando A, D’Attoma B, Prospero L, Tutino V, et al. The relationship between low serum vitamin D levels and altered intestinal barrier function in patients with IBS diarrhoea undergoing a long-term low-FODMAP diet: novel observations from a clinical trial. Nutrients. 2021 Mar; 13(3): 1011. doi: 10.3390/nu13031011. DOI: https://doi.org/10.3390/nu13031011

Sikaroudi MK, Mokhtare M, Shidfar F, Janani L, Kashani AF, Masoodi M, et al. Effects of vitamin D3 supplementation on clinical symptoms, quality of life, serum serotonin (5-hydroxytryptamine), 5-hydroxy-indole acetic acid, and the ratio of 5-HIAA/5-HT in patients with diarrhea-predominant irritable bowel syndrome: A randomized clinical trial. EXCLI Journal. 2020; 19: 652.

Naderpoor N, Mousa A, Fernanda Gomez Arango L, Barrett HL, Dekker Nitert M, de Courten B. Effect of vitamin D supplementation on faecal microbiota: a randomised clinical trial. Nutrients. 2019 Nov; 11(12): 2888. doi: 10.3390/nu11122888. DOI: https://doi.org/10.3390/nu11122888

Williams CE, Williams EA, Corfe BM. Vitamin D status in irritable bowel syndrome and the impact of supplementation on symptoms: what do we know and what do we need to know? European Journal of Clinical Nutrition. 2018 Oct; 72(10): 1358-63. doi: 10.1038/s41430-017-0064-z. DOI: https://doi.org/10.1038/s41430-017-0064-z

Quigley EM, Fried M, Gwee KA, Khalif I, Hungin AP, Lindberg G, et al. World Gastroenterology Organisation global guidelines irritable bowel syndrome: A global perspective update September 2015. Journal of Clinical Gastroenterology. 2016 Oct; 50(9): 704-13. doi: 10.1097/MCG.0000000000000653. DOI: https://doi.org/10.1097/MCG.0000000000000653

Chao YS, Brunel L, Faris P, Veugelers PJ. The importance of dose, frequency and duration of vitamin D supplementation for plasma 25-hydroxyvitamin D. Nutrients. 2013 Oct; 5(10): 4067-78. doi: 10.3390/nu5104067. DOI: https://doi.org/10.3390/nu5104067

Hlavaty T, Krajcovicova A, Koller T, Toth J, Nevidanska M, Huorka M, et al. Higher vitamin D serum concentration increases health related quality of life in patients with inflammatory bowel diseases. World Journal of Gastroenterology: WJG. 2014 Nov; 20(42): 15787. doi: 10.3748/wjg.v20.i42.15787. DOI: https://doi.org/10.3748/wjg.v20.i42.15787